JDG — Judges Scientific Income Statement
0.000.00%
Last trade - 00:00
- £761.15m
- £812.95m
- £136.10m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 82.5 | 79.9 | 91.3 | 113 | 136 |
Cost of Revenue | |||||
Gross Profit | 51.8 | 48.9 | 58 | 77.1 | 94.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 68.4 | 69.7 | 75.7 | 95 | 115 |
Operating Profit | 14.1 | 10.2 | 15.6 | 18.2 | 21.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 13.6 | 9.47 | 14.9 | 16 | 13.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.9 | 8.65 | 12.9 | 12.8 | 9.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 11.4 | 8.22 | 12.7 | 12.4 | 9.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 11.4 | 8.22 | 12.7 | 12.4 | 9.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.95 | 1.56 | 2.1 | 2.31 | 1.46 |
Dividends per Share | |||||
Special Dividends per Share |